The artificial intelligence drug developer has closed a $225m round led by SoftBank Vision Fund 2, which has offered a further $300m in funding.

Koch Disruptive Technologies returned to reinvest in the endpoint cybersecurity software provider, helping boost its overall funding to more than $152m.

Allied Minds portfolio company OcuTerra Therapeutics has secured $14.6m in funding.

Less than two months after closing a $100m series C round, the Dundee spinout has raised $225m in a series D led by SoftBank Vision Fund 2.

Lilly Asia Ventures co-led a $61.7m round for the endoscopy technology developer that was also backed by Medtronic.

Renal care provider InterWell Health and skincare product manufacturer Make Essence both raised approximately $46m while Salesforce-backed JazzHR agreed a merger.

European affiliates of Tencent provided nearly half of the $502m secured by the social network operator at a $2.1bn valuation earlier this month.

Prosus has led the on-demand home services provider’s latest round, which was reportedly secured at a $2bn valuation, pushing its total funding past $370m.

Exor, Coinbase Ventures and DRW Venture Capital have all invested in Crusoe Energy Systems, which owns a network of flared gas-powered data centres.

China Medical System and a WuXi Biologics industry investment fund were among the participants in the antibody therapy developer's $69.3m series A round.